COVID-19 vaccine with patch delivery technology enters preclinical testing at UC Davis

(University of California - Davis) Verndari Inc., a stage biopharmaceutical company, announced today that it will begin preclinical testing this week at UC Davis' Mouse Biology Program to evaluate a potential vaccine and delivery system for COVID-19.